Thermo Fisher Scientific today announced a strategic collaboration with drug delivery system provider SHL Medical. The collaboration coincides with the expansion of sterile fill-finish and auto-injector final assembly capacity at its Ridgefield, New Jersey site. Together, Thermo Fisher says its investments establish a fully integrated U.S.-based offering across sterile manufacturing, device assembly and commercial packaging […]
Drug-Device Combinations
Medtronic cuts 2026 guidance on private equity charge related to MiniMed approval
Medtronic (NYSE:MDT) said in an SEC filing that it lowered its full-year guidance after a one-time charge related to its MiniMed diabetes unit. Last week, MiniMed announced FDA clearance for the MiniMed Flex, a next-generation automated insulin delivery system. Clearance came “several months earlier than anticipated,” according to the filing, facilitating earlier commercialization. R&D for […]
Tandem Diabetes Care reports positive findings for Control-IQ in low-bolusing youths
Tandem Diabetes Care (Nasdaq:TNDM) has shared new findings supporting the use of its Control-IQ technology in type 1 diabetes. San Diego-based Tandem’s study aimed to assess the differences in time in range (TIR) between automated insulin delivery (AID) systems in youth with low bolus frequency. It compared Tandem Control-IQ technology with an undisclosed disposable patch-based […]
Embecta to acquire auto-injector maker Owen Mumford for up to $199.4M
Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited. Owen Mumford, a privately held, UK-based company, develops and manufactures medical devices and drug delivery technologies. Embecta, the former BD Diabetes business, agreed to acquire Owen Mumford with an upfront cash payment of approximately $133 million (£100 million). […]
MiniMed wins FDA clearance for next-gen Flex insulin pump
MiniMed (Nasdaq:MMED) announced today that it received FDA clearance for the MiniMed Flex next-generation insulin pump. Flex, a discreet, smartphone-controlled insulin pump, was designed by the company — which just went public as part of its separation from Medtronic — to seamlessly fit into everyday life. Clearance covers individuals aged 7 and older with type […]
The biggest diabetes tech news out of ATTD 2026
Diabetes technology innovators gathered in Barcelona last week for the 19th annual Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026). At ATTD 2026, a range of companies shared the latest updates, including product launches, new clinical data, enhancements to existing offerings and more. Topics included automated insulin delivery, continuous glucose monitors (CGMs), and breakthroughs […]
SiBionics highlights benefits of AI in CGM tech
SiBionics shared new findings about the use of AI in continuous glucose monitor (CGM) technologies. The China-based company shared new perspectives on AI at the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Barcelona. It outlined how AI can extend the value of CGM technology beyond just monitoring. SiBionics develops the […]
Senseonics reports sustained year-long CGM implant outcomes, insulin pump integration benefits
Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive impact of the world’s first year-long continuous glucose monitor (CGM). The company shared findings at the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Barcelona. […]
Insulet issues warning on certain Omnipod 5 pumps due to manufacturing issue
Insulet (Nasdaq:PODD) today initiated a voluntary medical device correction for specific lots of Omnipod 5 insulin pump pods. Omnipod 5 — the world’s first available tubeless, wearable, automated insulin delivery system — is a patch-based pump system designed to proactively correct for glucose highs every five minutes and protect against lows with insulin dosing. Acton, […]
Insulet shares study outcomes supporting fully closed-loop insulin pump for type 2 diabetes
Insulet (Nasdaq:PODD) today shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes. The maker of the Omnipod 5 — the world’s first available tubeless, wearable, automated insulin delivery system — said during a 2025 Investor Day event that it plans to bring its first fully closed-loop system […]
